MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-22-0006081
Lupitas Pharmaceuticals Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹1.03 Cr
▲ 12% YoY
Net profit · FY 2026
₹97,776
Net margin 0.9%
EBITDA · FY 2026
₹1.22 Lakh
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Employees · EPFO
9
Provident fund records
Directors on board
6
As per MCA filings
About Lupitas Pharmaceuticals Private Limited
Data last updated:
Lupitas Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2014PTC079490. Its GSTIN is 24AACCL6744K1ZB (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Ghanshyam Parsottambhai Laheri and Hetalben Dipakbhai Bhadiyadara.
Its last annual general meeting (AGM) was held on 30 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 33 Swaminarayan Nagar – 1 Near Kalakunj Varachha Road, Surat, Gujarat, India – 395006.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.03 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹97,776 (net margin 0.9%) and EBITDA of ₹1.22 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 9% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lupitas Pharmaceuticals.
Lupitas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0006081). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lupitaspharmaceuticals.com.
Company details
CIN U24100GJ2014PTC079490
Registration Number 079490
Incorporation Date 31 March 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-22-0006081
Key People
Ghanshyam Parsottambhai Laheri Director Hetalben Dipakbhai Bhadiyadara Director Kishorkumar Maganbhai Kachhadiya Director Recognitions & Rankings of Lupitas Pharmaceuticals
Contact details
Lupitas Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its website is lupitaspharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address33 Swaminarayan Nagar – 1 Near Kalakunj Varachha Road, Surat, Gujarat, India – 395006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lupitas Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lupitas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lupitas Pharmaceuticals operates one associated brand: Lupitas Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a CDMO specializing in the manufacturing of solid drug formulations. | lupitaspharmaceuticals.com |
Business activity
The main business activity of Lupitas Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Lupitas Pharmaceuticals Private Limited, buy the company report.
Financials of Lupitas Pharmaceuticals Private Limited
FY 2026 filings availableLupitas Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (up 12% YoY) for FY 2026.
Revenue · FY 2026
₹1.03 Cr ▲ 12%
Net profit · FY 2026
₹97,776 margin 0.9%
EBITDA · FY 2026
₹1.22 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 1%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 1%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 12% growth in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.03 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97,776 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lupitas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lupitas Pharmaceuticals Private Limited
Lupitas Pharmaceuticals has 6 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ghanshyam Parsottambhai Laheri | Director | 31 Mar 2014 | 12 Years 7 Months | Current |
| Hetalben Dipakbhai Bhadiyadara | Director | 12 Jun 2015 | 11 Years 5 Months | Current |
| Kishorkumar Maganbhai Kachhadiya | Director | 12 Jun 2015 | 11 Years 5 Months | Current |
| Ashish Rameshchandra Pandya | Director | 18 Sep 2015 | 11 Years 1 Months | Current |
| Pareshkumar Ramjibhai Dhameliya Also directs: Delphard Healthcare Private Limited, Times Vacanza Private Limited | Director | 04 Aug 2021 | 5 Years 3 Months | Current |
| Bhanuben Pravinbhai Vekariya | Director | 19 May 2026 | 0 Years 5 Months | Current |
Auditor
Lupitas Pharmaceuticals Private Limited is audited by YOGESH PANCHANI for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YOGESH PANCHANI | FY 2026 | 156359 |
Shareholding
The shareholding of Lupitas Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lupitas Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lupitas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lupitas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lupitas Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
9
Active EPFO establishments
1
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 9 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Lupitas Pharmaceuticals Private Limited, buy the company report.
GST
Lupitas Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCL6744K1ZB | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lupitas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lupitas Pharmaceuticals Private Limited has 29 board changes on record since 2014: 6 appointments and 23 cessations. The latest: Bhanuben Pravinbhai Vekariya was appointed as Director on 19 May 2026.
AGM
Lupitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2026 as per latest MCA records.
Appointed
Bhanuben Pravinbhai Vekariya was appointed as Director.
Filing
Lupitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Pravinbhai Govindbhai Vekariya ceased to be Director.
Ceased
Pankajkumar Muljibhai Siddhapara ceased to be Additional Director.
Ceased
Vipulbhai Madhubhai Buha ceased to be Additional Director.
Ceased
Haresh Karamashibhai Intaliya ceased to be Additional Director.
Ceased
Mukeshkumar Bhupatbhai Padsala ceased to be Additional Director.
Ceased
Vijay Premjibhai Narola ceased to be Additional Director.
Ceased
Dhirubhai Haribhai Polra ceased to be Director.
Ceased
Rashmiben Kishorkumar Padsala ceased to be Director.
Ceased
Ashaben Hareshbhai Intaliya ceased to be Director.
20 earlier events are in the company report.
Frequently asked questions
Lupitas Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 March 2014 (12+ years old) and is registered under CIN U24100GJ2014PTC079490.
Lupitas Pharmaceuticals has 6 current directors:
- Ghanshyam Parsottambhai Laheri - Director
- Hetalben Dipakbhai Bhadiyadara - Director
- Kishorkumar Maganbhai Kachhadiya - Director
- Ashish Rameshchandra Pandya - Director
- Pareshkumar Ramjibhai Dhameliya - Director
- Bhanuben Pravinbhai Vekariya - Director
The latest financial statements of Lupitas Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Lupitas Pharmaceuticals is 24AACCL6744K1ZB, registered in Gujarat.
The CIN (Corporate Identification Number) of Lupitas Pharmaceuticals is U24100GJ2014PTC079490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lupitas Pharmaceuticals was incorporated on 31 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Bhanuben Pravinbhai Vekariya was appointed as Director on 19 May 2026. Pravinbhai Govindbhai Vekariya ceased to be Director on 31 Mar 2026. Pankajkumar Muljibhai Siddhapara ceased to be Additional Director on 02 Sep 2024. Lupitas Pharmaceuticals has 29 board changes on record in total.
Yes, Lupitas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0006081).
Lupitas Pharmaceuticals can be reached through the website lupitaspharmaceuticals.com. Its registered office is in Surat, Gujarat, India.
The registered office of Lupitas Pharmaceuticals is at 33 Swaminarayan Nagar – 1 Near Kalakunj Varachha Road, Surat, Gujarat, India – 395006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages